XML 30 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statement of Earnings - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Net Sales $ 43,653 $ 43,075 $ 34,608
Cost of products sold, excluding amortization of intangible assets 19,142 18,537 15,003
Amortization of intangible assets 2,013 2,047 2,132
Research and development 2,888 2,742 2,420
Selling, general and administrative 11,248 11,324 9,696
Total Operating Cost and Expenses 35,291 34,650 29,251
Operating Earnings 8,362 8,425 5,357
Interest expense 558 533 546
Interest income (183) (43) (46)
Net foreign exchange (gain) loss 2 1 (8)
Other (income) expense, net (321) (277) (103)
Earnings from Continuing Operations Before Taxes 8,306 8,211 4,968
Taxes on Earnings from Continuing Operations 1,373 1,140 497
Earnings from Continuing Operations 6,933 7,071 4,471
Net Earnings from Discontinued Operations, net of taxes 0 0 24
Net Earnings $ 6,933 $ 7,071 $ 4,495
Basic Earnings Per Common Share --      
Continuing Operations (in dollars per share) $ 3.94 $ 3.97 $ 2.51
Discontinued Operations (in dollars per share) 0 0 0.01
Net Earnings (in dollars per share) 3.94 3.97 2.52
Diluted Earnings Per Common Share --      
Continuing Operations (in dollars per share) 3.91 3.94 2.49
Discontinued Operations (in dollars per share) 0 0 0.01
Net Earnings (in dollars per share) $ 3.91 $ 3.94 $ 2.50
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) 1,753 1,775 1,773
Dilutive Common Stock Options (in shares) 11 14 13
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) 1,764 1,789 1,786
Outstanding Common Stock Options Having No Dilutive Effect (in shares) 3 0 9